Inga C.
- Country
- Germany
- Department
- Klinik für Neurologie mit Institut für Translationale Neurologie
Research Overview
- Evaluation of Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of LY3962681 in Healthy Volunteers and Patients with Parkinson's Disease
- Evaluation of Long-Term Safety and Tolerability of Tavapadon in Patients with Parkinson's Disease: A 58-Week Open-Label Multinational Study
- Phase 2 Randomized, Double-blind, Placebo-controlled Study of Emrusolmin in Adult Patients with Multiple System Atrophy
Data & Insights
Has run more than one trial at 47 of 151 partner sites.
Specializations
Neurodegenerative Disorders
This investigator specializes in treating and researching neurodegenerative conditions, with a particular focus on movement disorders.
- Parkinson's Disease Management
- Multiple System Atrophy Treatment
- Progressive Neurological Disorders
The investigator explores innovative therapeutic approaches for addressing motor and non-motor symptoms in these conditions.
Movement Disorders
Dedicated to advancing treatment options for movement disorders, with expertise in evaluating novel therapeutic compounds.
- Motor Symptom Management
- Disease Progression Assessment
- Long-term Treatment Strategies
The research focuses on understanding and treating complex movement disorder manifestations.
Therapeutic Innovation
Actively involved in investigating novel therapeutic agents for neurological conditions.
- ROCK Inhibitor Studies
- Alpha-synuclein Targeted Therapies
- Innovative Drug Development
Evaluates emerging treatments through rigorous clinical research protocols.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.